沛爾生醫-創 News Releases

Peier Biomedical - Chuang's 115th Annual General Meeting Approves Removal of Director's Non-Competition Restriction

On June 18, 115, Peier Biomedical - Chuang's shareholders approved the lifting of non-competition re… · 2026-06-18

Percell Biomed-Genesis Announces Designated Corporate Director Representative for Shareholders' Meeting on 115/06/18

Percell Biomed-Genesis has announced that Acer Incorporated has designated Lin Wen-Rong as its corpo… · 2026-06-18

Peier Biomedical - Chuang Announces Key Resolutions from the 115th Annual Shareholders Meeting

Peier Biomedical - Chuang held its 115th annual shareholders meeting on June 18, 2026, approving the… · 2026-06-18

PerMed Biosciences Announces Financial and Business Information Due to Securities Trading Alert Threshold on Centralized Market

PerMed Biosciences discloses financial information as its securities met the Taiwan Stock Exchange's… · 2026-06-18

Peil Biomedical Subsidiary Receives NMPA Approval for Phase I Clinical Trial of RA Drug PP011 in China

Peil Biomedical announced that its wholly-owned subsidiary, Peil (Shanghai) Pharmaceutical Technolog… · 2026-06-02

[Pei-Er Biomedical] The company is invited to participate in the 'Taishin 2026 Q2 Global Investment Forum' hosted by Taishin Securities

Pei-Er Biomedical announced its participation in the 'Taishin 2026 Q2 Global Investment Forum' hoste… · 2026-05-27

6949 Peil Biomedical: Announcement Regarding Change in R&D Leadership

Peil Biomedical (6949) announced on May 20 a leadership change in its R&D department. The Deputy R&D… · 2026-05-20

[Pell Bio-Medical] Announcement of Change in Head of R&D

Pell Bio-Medical announced that Deputy Head of R&D Lin Wei-Chi will resign for personal career plann… · 2026-05-20

Pelobiomed-Tron Announces Board Approval of Q1 115 Consolidated Financial Statements

Pelobiomed-Tron announced that its Q1 2026 consolidated financial statements were approved by the bo… · 2026-05-05

【Peir Biomedical-Innovation】Announcement of the Record Date for the Conversion of Employee Stock Warrants into Common Shares as Resolved by the Board of Directors

Peir Biomedical-Innovation announced the board's resolution on May 5, 2026, setting the record date … · 2026-05-05

【PAILONG BIOMEDICAL INC.】Announcement of Change in Capital Increase Fund Utilization Plan for 2025

PAILONG BIOMEDICAL INC. announced a change in the utilization plan for funds raised from its 2025 ca… · 2026-05-05

Pelobiomed-Tron Announces Appointment of Chief Product Development and Marketing Officer

Pelobiomed-Tron announced the appointment of Jian Wenbin as the new Chief Product Development and Ma… · 2026-05-05

Pelobiomed-Tron Announces Appointment of Chief Product Development and Marketing Officer

Pelobiomed-Tron announced the appointment of Jian Wenbin as the new Chief Product Development and Ma… · 2026-05-05

Pelobiomed-Tron Announces Board Approval of Q1 115 Consolidated Financial Statements

Pelobiomed-Tron announced that its Q1 2026 consolidated financial statements were approved by the bo… · 2026-05-05

[Pels Biotech] Institutional Director Appoints Representative to Attend the Board Meeting on 2026/05/05

Pels Biotech announced that Acer Inc., as an institutional director, has appointed Kuo Chien-Cheng, … · 2026-05-05

[Pels Biotech] Institutional Director Appoints Representative to Attend the Board Meeting on 2026/05/05

Pels Biotech announced that Acer Inc., as an institutional director, has appointed Kuo Chien-Cheng, … · 2026-05-05

Per Biotechnology-Chuang Announces Board Approval for Amendment of Company Articles of Incorporation to Change Par Value Per Share

Per Biotechnology-Chuang has announced that its board of directors approved an amendment to the comp… · 2026-05-05

Per Biotechnology-Chuang Announces Board Approval for Amendment of Company Articles of Incorporation to Change Par Value Per Share

Per Biotechnology-Chuang has announced that its board of directors approved an amendment to the comp… · 2026-05-05

【Peir Biomedical-Innovation】Announcement of the Record Date for the Conversion of Employee Stock Warrants into Common Shares as Resolved by the Board of Directors

Peir Biomedical-Innovation announced the board's resolution on May 5, 2026, setting the record date … · 2026-05-05

PerkinElmer Biomedical Announces Board Approval to Change Stock Transfer Agent

PerkinElmer Biomedical Co., Ltd. announced that its board of directors has approved the change of it… · 2026-05-05

PerkinElmer Biomedical Announces Board Approval to Change Stock Transfer Agent

PerkinElmer Biomedical Co., Ltd. announced that its board of directors has approved the change of it… · 2026-05-05

[Perpetual Bio-Innovation] Announcement from the Board of Directors Regarding the Issuance of Restricted Employee Rights New Shares

Perpetual Bio-Innovation's board of directors resolved to issue Restricted Stock Units (RSUs) to emp… · 2026-05-05

[Perpetual Bio-Innovation] Announcement from the Board of Directors Regarding the Issuance of Restricted Employee Rights New Shares

Perpetual Bio-Innovation's board of directors resolved to issue Restricted Stock Units (RSUs) to emp… · 2026-05-05

Paier Bio-Medical - Genesis: Board Resolution to Convene Shareholders' Meeting (New Proposals Added)

Paier Bio-Medical - Genesis has decided to convene a shareholders' meeting on June 18, 2026, to deli… · 2026-05-05

Paier Bio-Medical - Genesis: Board Resolution to Convene Shareholders' Meeting (New Proposals Added)

Paier Bio-Medical - Genesis has decided to convene a shareholders' meeting on June 18, 2026, to deli… · 2026-05-05

【PAILONG BIOMEDICAL INC.】Announcement of Change in Capital Increase Fund Utilization Plan for 2025

PAILONG BIOMEDICAL INC. announced a change in the utilization plan for funds raised from its 2025 ca… · 2026-05-05

[PL BioMed] May 2026 Revenue Reaches NT$3 Million (YoY +18.8%)

PL BioMed (6949) announced its revenue for May 2026 reached NT$2,691 thousand (approximately NT$3 mi… · 2026-05-01

[Pure Blood Biotech] Announcement of Board Meeting Date for Q1 2026 Consolidated Financial Report

Pure Blood Biotech has announced that its board of directors will meet on May 5, 2026, to discuss an… · 2026-04-27

[Pure Blood Biotech] Announcement of Board Meeting Date for Q1 2026 Consolidated Financial Report

Pure Blood Biotech has announced that its board of directors will meet on May 5, 2026, to discuss an… · 2026-04-27

[Peijia Bio] PL001 (CD19 CAR-T) Efficacy Passes Phase II Interim Analysis with Statistical Significance

Peijia Bio's CAR-T therapy PL001 achieved significant success in its Phase II interim analysis for B… · 2026-04-23

[Peijia Bio] PL001 (CD19 CAR-T) Efficacy Passes Phase II Interim Analysis with Statistical Significance

Peijia Bio's CAR-T therapy PL001 achieved significant success in its Phase II interim analysis for B… · 2026-04-23

[Pei Er Biomedical] Announcement of Obtaining the 2025 Internal Control Project Review Report

Pei Er Biomedical has obtained an internal control review report with an unqualified opinion as part… · 2026-04-20

Pure-Biomedical Announces Trading Information Disclosure Due to Securities Meeting Public Notice Standards, Releasing Major Financial and Business Information for Investor Clarity

Pure-Biomedical is announcing major financial and business information as its securities have met th… · 2026-04-15

Pure-Biomedical Announces Trading Information Disclosure Due to Securities Meeting Public Notice Standards, Releasing Major Financial and Business Information for Investor Clarity

Pure-Biomedical is announcing major financial and business information as its securities have met th… · 2026-04-15

【Per Biotechnology-Creativity】April 2026 Monthly Revenue 0.03 Billion NTD (YoY +107.9%)

Per Biotechnology-Creativity announced its monthly revenue for April 2026 reached 0.03 billion NTD, … · 2026-04-01

【Per Biotechnology-Creativity】April 2026 Monthly Revenue 0.03 Billion NTD (YoY +107.9%)

Per Biotechnology-Creativity announced its monthly revenue for April 2026 reached 0.03 billion NTD, … · 2026-04-01

[PEL-BIOTECH-Inc] March 2026 Monthly Revenue NT$2M (YoY +74.5%)

PEL-BIOTECH-Inc announced its monthly revenue for March 2026. Although the amount was small at NT$2 … · 2026-03-01

[PEL-BIOTECH-Inc] March 2026 Monthly Revenue NT$2M (YoY +74.5%)

PEL-BIOTECH-Inc announced its monthly revenue for March 2026. Although the amount was small at NT$2 … · 2026-03-01

Pelle Life Sciences-Emerging (6949): February 2026 Revenue Reaches 0.02 Hundred Million (+61.2% YoY)

Pelle Life Sciences-Emerging (6949) has announced its financial report for February 2026. The compan… · 2026-02-01

Pelle Life Sciences-Emerging (6949): February 2026 Revenue Reaches 0.02 Hundred Million (+61.2% YoY)

Pelle Life Sciences-Emerging (6949) has announced its financial report for February 2026. The compan… · 2026-02-01